Schedule for Master Class Live In Person
All times listed below are Central Time. Please adjust accordingly for your timezone.
October 21, 2022
-
6:45am - 7:15am
Registration and Breakfast
-
7:15am - 7:25am
Welcome and Opening Remarks
Session 1 - Malignant and Non-Malignant Hematology
Moderator: Jean M. Connors MD
-
7:25am - 8:10am
Non-Hodgkin and Hodgkin Lymphoma: An Individualized Treatment Approach
Ann S. LaCasce MD, MMSC -
8:10am - 8:55am
Myeloid Malignancies: Molecular Markets and Targeted Therapies
Daniel J. DeAngelo, MD, PhD -
8:55am - 9:20am
Molecular Drivers of Myeloproliferative Neoplasms: Impact on Diagnosis, Assessment, and Management
Ayalew Tefferi, MD -
9:20am - 9:45am
Multiple Myeloma: Current Evidence-Based Management
Kenneth C. Anderson, MD -
9:45am - 10:10am
Chronic Lymphocytic Leukemia: Evaluating the Rapidly Changing Treatment Landscape
Matthew S. Davids MD, MMSC -
10:10am - 10:25am
Refreshment Break
-
10:25am - 10:55am
Current and Future Treatment Strategies for Cancer Associated Thrombosis
Jean M. Connors MD -
10:55am - 11:25am
Reducing the Sickle Cell Disease Burden with Novel Treatment Targets
Alexis A. Thompson MD, MPH -
11:25am - 12:00pm
Panel Discussion
All Faculty -
12:00pm - 12:45pm
Lunch
October 21, 2022
Session 2 – Women’s Cancers and Supportive Care
Moderator: Harold J. Burstein MD, PhD
Supportive Care
-
12:45pm - 1:10pm
Sexual Health in Cancer Survivors
Sharon L. Bober, PhD -
1:10pm - 1:35pm
Supportive and Palliative Care: Managing Symptoms and Toxicities to Improve Patient Outcomes
Janet L. Abrahm, MD -
1:35pm - 1:55pm
Supportive Care Questions and Answers
-
1:55pm - 2:10pm
Refreshment Break
Breast Cancers
-
2:10pm - 2:50pm
HER2-Positive Breast Cancer and Triple-Negative Breast Cancer: An Evolving Treatment Landscape
Nancy U. Lin MD -
2:50pm - 3:15pm
Advances in Hormone Receptor Positive Breast Cancer and Hereditary Breast Cancer Syndromes
Harold J. Burstein MD, PhD
Gynecologic Cancers
-
3:30pm - 4:00pm
Molecular Advances and Emerging Treatment Strategies In Ovarian Cancer
Ursula A. Matulonis, MD -
4:00pm - 4:25pm
Molecular Advances and Emerging Treatment Strategies In Endometrial Cancer
Joyce F. Liu, MD, MPH -
4:25pm - 4:55pm
Panel Discussion
All Faculty -
4:55pm
Day One Adjournment
October 22, 2022
-
6:45am - 7:15am
Registration and Breakfast
-
7:15am - 7:20am
Welcome Back
Session 3 – Gastrointestinal Cancers and Sarcoma
Moderator: Robert J. Mayer MD
Gastrointestinal Cancers
-
7:20am - 8:05am
Colorectal Cancer: Molecular Markers and Evidence-Based Best Practices for Systemic Treatment
Robert J. Mayer MD -
8:05am - 8:25am
Novel Treatments for Neuroendocrine Tumors: Using Patient and Tumor Characteristics to Guide Treatments
Jennifer A. Chan, MD, MPH -
8:25am - 9:10am
Novel Approaches for the Management of Esophageal, Gastric, and Pancreatic Cancers
Peter C. Enzinger, MD -
9:10am - 9:30am
Hepatobiliary Cancer: Predictive Biomarkers, Novel Agents, and Patient Monitoring
Thomas A. Abrams, MD -
9:30am - 9:45am
Refreshment Break
-
9:45am - 10:25am
Hereditary Gastrointestinal Cancers: From Family History to Management with Combination Therapy
Matthew B. Yurgelun, MD -
10:25am - 10:55am
Panel Discussion
All Faculty
Sarcoma
-
10:55am - 11:25am
Best Practices and Expanding Treatment Options in Soft Tissue Sarcoma
George D. Demetri, MD -
11:25am - 11:35am
Sarcoma Questions and Answers
-
11:35am - 12:20pm
Lunch
October 22, 2022
Session 4 – Head, Neck and Lung Cancers and Melanoma
Moderator: Bruce E. Johnson MD
Head, Neck and Lung Cancers
-
12:20pm - 1:00pm
Emerging Agents in the Multimodal Management of Head, Neck, and Thyroid Cancers
Robert I. Haddad, MD -
1:00pm - 1:50pm
NSCLC and SCLC: Molecular Testing and Emerging Treatment Options
Bruce E. Johnson MD
Melanoma Cancer
-
1:50pm - 2:25pm
Evidence-Based Treatment Approaches for Adjuvant, Advanced, and Metastatic Melanoma
F. Stephen Hodi, MD -
2:25pm - 2:55pm
Panel Discussion
All Faculty -
2:55pm - 3:10pm
Refreshment Break
October 22, 2022
Session 5 – Genitourinary Cancers
Moderator: Bruce E. Johnson MD
-
3:10pm - 4:00pm
Prostate Cancer: An Evolving Treatment Landscape
Mary Ellen Taplin, MD -
4:00pm - 4:35pm
Treatment Selection in Renal Cell and Urothelial Carcinoma: Integrating Novel Agents into Daily Practice
Robert Dreicer, MD -
4:35pm - 5:05pm
Panel Discussion
All Faculty -
5:05pm - 5:10pm
Closing Remarks
-
5:10pm
Course Adjournment